103 related articles for article (PubMed ID: 33463281)
1. Synthesis and Characterization of a Biocomposite Bone Bandage for Controlled Delivery of Bone-Active Drugs in Fracture Nonunions.
Raina DB; Glencross A; Chaher N; Liu Y; Lidgren L; Isaksson H; Tägil M
ACS Biomater Sci Eng; 2020 May; 6(5):2867-2878. PubMed ID: 33463281
[TBL] [Abstract][Full Text] [Related]
2. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
3. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Raina DB; Isaksson H; Teotia AK; Lidgren L; Tägil M; Kumar A
J Control Release; 2016 Aug; 235():365-378. PubMed ID: 27252151
[TBL] [Abstract][Full Text] [Related]
4. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
5. Biomodulation of an implant for enhanced bone-implant anchorage.
Raina DB; Larsson D; Sezgin EA; Isaksson H; Tägil M; Lidgren L
Acta Biomater; 2019 Sep; 96():619-630. PubMed ID: 31301423
[TBL] [Abstract][Full Text] [Related]
6. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats.
Širka A; Raina DB; Isaksson H; Tanner KE; Smailys A; Kumar A; Tarasevičius Š; Tägil M; Lidgren L
Tissue Eng Part A; 2018 Dec; 24(23-24):1753-1764. PubMed ID: 29855219
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model.
Lee JH; Baek HR; Lee KM; Zheng GB; Shin SJ; Jin YZ
Growth Factors; 2015; 33(3):220-8. PubMed ID: 26099999
[TBL] [Abstract][Full Text] [Related]
8. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.
Raina DB; Isaksson H; Hettwer W; Kumar A; Lidgren L; Tägil M
Sci Rep; 2016 May; 6():26033. PubMed ID: 27189411
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
[TBL] [Abstract][Full Text] [Related]
11. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
13. [ECTOPIC OSTEOGENESIS EVALUATION OF RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 LOADED CHITOSAN/DEXTRAN SULFATE BY MICRO-CT].
Xia Y; Yu X; Zhang Y; Yin Q; Xia H; Zheng X; Xie H; Huang X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Mar; 30(3):286-91. PubMed ID: 27281871
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G
Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748
[TBL] [Abstract][Full Text] [Related]
15. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates.
Murphy CM; Schindeler A; Gleeson JP; Yu NY; Cantrill LC; Mikulec K; Peacock L; O'Brien FJ; Little DG
Acta Biomater; 2014 May; 10(5):2250-8. PubMed ID: 24456759
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion.
Tian X; Vater C; Raina DB; Findeisen L; Matuszewski LM; Tägil M; Lidgren L; Winkler A; Gottwald R; Modler N; Schaser KD; Disch AC; Zwingenberger S
Bioact Mater; 2024 Jun; 36():256-271. PubMed ID: 38487704
[TBL] [Abstract][Full Text] [Related]
17. Nano-copper-bearing stainless steel promotes fracture healing by accelerating the callus evolution process.
Wang L; Li G; Ren L; Kong X; Wang Y; Han X; Jiang W; Dai K; Yang K; Hao Y
Int J Nanomedicine; 2017; 12():8443-8457. PubMed ID: 29225463
[TBL] [Abstract][Full Text] [Related]
18. Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation.
Markeviciute V; Puthia M; Arvidsson L; Liu Y; Törnquist E; Tengattini A; Huang J; Bai Y; Vater C; Petrolis R; Zwingenberger S; Krisciukaitis A; Smailys A; Lukosevicius S; Stravinskas M; Isaksson H; Tarasevicius S; Lidgren L; Tägil M; Raina DB
Acta Biomater; 2024 Apr; 179():354-370. PubMed ID: 38490481
[TBL] [Abstract][Full Text] [Related]
19. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.
Raina DB; Matuszewski LM; Vater C; Bolte J; Isaksson H; Lidgren L; Tägil M; Zwingenberger S
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33246951
[TBL] [Abstract][Full Text] [Related]
20. Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.
Quinlan E; Thompson EM; Matsiko A; O'Brien FJ; López-Noriega A
J Control Release; 2015 Jun; 207():112-9. PubMed ID: 25817394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
